Peptide-based biomaterials for protease-enhanced drug delivery

Area of Science:

• Biomaterials science
• Drug delivery systems
• Protease-activated therapies

Background:

• Controlled drug delivery is crucial for targeted therapies and personalized medicine.
• Environmental stimuli-responsive systems offer precise therapeutic payload release.
• Proteases are key biomarkers and therapeutic targets in various diseases.

Purpose of the Study:

• To design and characterize self-assembling peptide sequences for protease-mediated drug delivery.
• To create a stimuli-responsive hydrogel scaffold that degrades upon protease activity.
• To demonstrate controlled release of therapeutic payloads triggered by disease-associated proteases.

Main Methods:

• Synthesis of peptide sequences with protease-cleavable regions and self-assembly motifs.
• Characterization of peptide self-assembly into hydrogel scaffolds in aqueous solutions.
• Enzymatic degradation studies using disease-associated proteases to assess matrix breakdown.
• Demonstration of therapeutic peptide release from the hydrogel matrix upon protease treatment.

Main Results:

• Peptides successfully self-assembled into a stable hydrogel scaffold in aqueous environments.
• The hydrogel matrix exhibited controlled degradation in the presence of specific proteases.
• Degradation rates were tunable by modifying peptide composition.
• Protease-mediated release of an incorporated model therapeutic peptide was successfully demonstrated.

Conclusions:

• Self-assembling peptide hydrogels can be designed for controlled, protease-triggered drug release.
• This system offers a promising platform for functionally targeted drug delivery applications.
• The tunable nature of the peptide sequences allows for fine-tuning of drug release kinetics.